ID   RUNX2_RAT               Reviewed;         218 AA.
AC   Q9Z2J9; Q99NC7;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 2.
DT   24-JUL-2024, entry version 152.
DE   RecName: Full=Runt-related transcription factor 2;
DE   AltName: Full=Core-binding factor subunit alpha-1;
DE            Short=CBF-alpha-1;
DE   AltName: Full=Osteoblast-specific transcription factor 2;
DE            Short=OSF-2;
DE   Flags: Fragments;
GN   Name=Runx2; Synonyms=Cbfa1, Osf2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-98.
RX   PubMed=9651525; DOI=10.1016/s0378-1119(98)00227-3;
RA   Xiao Z.S., Thomas R., Hinson T.K., Quarles L.D.;
RT   "Genomic structure and isoform expression of the mouse, rat and human
RT   Cbfa1/Osf2 transcription factor.";
RL   Gene 214:187-197(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 99-218.
RC   TISSUE=Osteoblast;
RA   Goseki M.S., Iimura T.;
RT   "Regulatory expression of rat CBFA1 in osteoblastic cells.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH OLFM2.
RX   PubMed=28062493; DOI=10.1161/atvbaha.116.308606;
RA   Shi N., Li C.X., Cui X.B., Tomarev S.I., Chen S.Y.;
RT   "Olfactomedin 2 regulates smooth muscle phenotypic modulation and vascular
RT   remodeling through mediating Runt-related transcription factor 2 binding to
RT   serum response factor.";
RL   Arterioscler. Thromb. Vasc. Biol. 37:446-454(2017).
CC   -!- FUNCTION: Transcription factor involved in osteoblastic differentiation
CC       and skeletal morphogenesis. Essential for the maturation of osteoblasts
CC       and both intramembranous and endochondral ossification. CBF binds to
CC       the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters,
CC       including murine leukemia virus, polyomavirus enhancer, T-cell receptor
CC       enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I)
CC       collagen, LCK, IL-3 and GM-CSF promoters. Inhibits KAT6B-dependent
CC       transcriptional activation. In osteoblasts, supports transcription
CC       activation: synergizes with SPEN/MINT to enhance FGFR2-mediated
CC       activation of the osteocalcin FGF-responsive element (OCFRE).
CC       {ECO:0000250|UniProtKB:Q13950}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha subunit
CC       binds DNA as a monomer and through the Runt domain. DNA-binding is
CC       increased by heterodimerization (By similarity). Interacts with XRCC6
CC       (Ku70) and XRCC5 (Ku80). Interacts with CCNB1, KAT6A and KAT6B.
CC       Interacts with HIVEP3. Interacts with IFI204. Interaction with SATB2;
CC       the interaction results in enhanced DNA binding and transactivation by
CC       these transcription factors. Binds to HIPK3. Interacts with FOXO1 (via
CC       a C-terminal region); the interaction inhibits RUNX2 transcriptional
CC       activity towards BGLAP. Interacts with FOXP3. Interacts with TMEM119.
CC       Interacts with OLFM2 (PubMed:28062493). Interacts with IPO7; the
CC       interaction inhibits RUNX2 nuclear translocation in osteoblasts (By
CC       similarity). {ECO:0000250|UniProtKB:Q08775,
CC       ECO:0000250|UniProtKB:Q13950, ECO:0000269|PubMed:28062493}.
CC   -!- INTERACTION:
CC       Q9Z2J9; P25977: Ubtf; NbExp=2; IntAct=EBI-6119952, EBI-15620127;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13950}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q08775}.
CC   -!- PTM: Phosphorylated; probably by MAP kinases (MAPK). Phosphorylation by
CC       HIPK3 is required for the SPEN/MINT and FGF2 transactivation during
CC       osteoblastic differentiation (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF053950; AAC77442.1; -; Genomic_DNA.
DR   EMBL; AB025797; BAB40441.1; -; mRNA.
DR   AlphaFoldDB; Q9Z2J9; -.
DR   BMRB; Q9Z2J9; -.
DR   SMR; Q9Z2J9; -.
DR   CORUM; Q9Z2J9; -.
DR   DIP; DIP-60266N; -.
DR   IntAct; Q9Z2J9; 2.
DR   STRING; 10116.ENSRNOP00000057733; -.
DR   PaxDb; 10116-ENSRNOP00000057733; -.
DR   UCSC; RGD:2282; rat.
DR   AGR; RGD:2282; -.
DR   RGD; 2282; Runx2.
DR   eggNOG; KOG3982; Eukaryota.
DR   InParanoid; Q9Z2J9; -.
DR   PhylomeDB; Q9Z2J9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0043425; F:bHLH transcription factor binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:RGD.
DR   GO; GO:0140296; F:general transcription initiation factor binding; IPI:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0048469; P:cell maturation; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0034224; P:cellular response to zinc ion starvation; IEP:RGD.
DR   GO; GO:0002063; P:chondrocyte development; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISO:RGD.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0036076; P:ligamentous ossification; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0002076; P:osteoblast development; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; IMP:RGD.
DR   GO; GO:0002051; P:osteoblast fate commitment; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045778; P:positive regulation of ossification; IMP:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0030278; P:regulation of ossification; ISO:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904383; P:response to sodium phosphate; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0060395; P:SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; ISO:RGD.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   Gene3D; 2.60.40.720; -; 1.
DR   InterPro; IPR000040; AML1_Runt.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd_sf.
DR   InterPro; IPR012346; p53/RUNT-type_TF_DNA-bd_sf.
DR   InterPro; IPR013524; Runt_dom.
DR   PANTHER; PTHR11950; RUNT RELATED; 1.
DR   PANTHER; PTHR11950:SF7; RUNT-RELATED TRANSCRIPTION FACTOR 2; 1.
DR   Pfam; PF00853; Runt; 1.
DR   PRINTS; PR00967; ONCOGENEAML1.
DR   SUPFAM; SSF49417; p53-like transcription factors; 1.
DR   PROSITE; PS51062; RUNT; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Differentiation; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..>218
FT                   /note="Runt-related transcription factor 2"
FT                   /id="PRO_0000174661"
FT   DOMAIN          67..195
FT                   /note="Runt"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00399"
FT   REGION          122..138
FT                   /note="Required for interaction with FOXO1"
FT                   /evidence="ECO:0000250"
FT   REGION          189..218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        189..208
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        204
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13950"
FT   NON_CONS        98..99
FT                   /evidence="ECO:0000305"
FT   NON_TER         218
SQ   SEQUENCE   218 AA;  24247 MW;  D6465458B60628A2 CRC64;
     MLHSPHKQPQ NHKCGANFLQ EDSKEALVFK WLISAGHYQP PRPTESVSAL STVHAVIFKA
     ASSIYNRGHK FYLEKKGGTM ASNSLFSAVT PCQQSFFWNK TLPVAFKVVA LGEVPDGTVV
     TVMAGNDENY SAELRNASAV MKNQVARFND LRFVGRSGRG KSFTLTITVF TNPPQVATYH
     RAIKVTVDGP REPRRHRQKL DDSKPSLFSD RLSDLGRI
//
